Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-1070770 in adults with major ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...

Seasonal affective disorder, or SAD, is a type of depression that's related to the changes in seasons. Symptoms typically ...

Shared biological, psychological, and social pathways put patients at risk for both, whether obesity or depression occurs ...

Creatine supplementation may modestly reduce depressive symptoms, but the effect is small, uncertain, and likely influenced ...

Imagine wading through severe depression for years, taking medication after medication, with no relief. Now, envision discovering that what you were facing was not major depression but bipolar ...

Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for ...

Scientists have developed a portable biosensor that can detect levels of BDNF, a protein linked to mental health conditions ...

Learn which supplements may help manage seasonal affective disorder (SAD) symptoms, including vitamin D, omega-3s, and more.

As the days shorten, the clocks roll back and the holiday season approaches, millions of Americans brace for seasonal ...

Kim Novak has been open about her struggles with bipolar disorder, which she said she first developed in the early 2000s.